Peregrine Pharmaceuticals shares owned by Portolan Capital Management
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Portolan Capital Management
from 13F filings
Historical chart of Portolan Capital Management investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Portolan Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Portolan Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.9M | 439k | 6.50 |
| 2022-12-31 | $483k | 35k | 13.77 |
| 2022-09-30 | $1.2M | 64k | 19.13 |
| 2022-06-30 | $2.9M | 192k | 15.26 |
| 2022-03-31 | $4.5M | 219k | 20.37 |
| 2021-12-31 | $6.3M | 216k | 29.18 |
| 2021-09-30 | $2.1M | 96k | 21.57 |
| 2021-06-30 | $8.1M | 318k | 25.65 |
| 2021-03-31 | $11M | 591k | 18.23 |
| 2020-12-31 | $13M | 1.1M | 11.54 |
| 2020-09-30 | $7.3M | 963k | 7.62 |
| 2020-06-30 | $2.9M | 435k | 6.57 |
More positions owned by Portolan Capital Management
View all positions for Portolan Capital Management